Product Details

Teva-Tobramycin

Tobramycin
300 mg/5 mL
Solution for Inhalation
5-mL Pack

DIN/PIN/NPN

02389622

Manufacturer

Teva Canada Limited

Formulary Listing Date

2016-03-30  

Unit Price

41.0985

Amount MOH Pays

41.0985

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Tobramycin 300 mg/5 mL Solution for Inhalation 5-mL Pack: For the management of cystic fibrosis patients with chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infections. Tobramycin is administered in alternating periods of 28 days. After 28 days of therapy, patients should stop therapy for the next 28 days, and then resume therapy for the next 28 day on / 28 day off cycle.

ATC Code

J01GB01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02239630 TOBI 60.8210 41.0985
02389622 Teva-Tobramycin 41.0985 41.0985
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph